Rhelion Life Sciences Corp. TRUFF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 26.82% | -86.32% | -16.76% | -13.96% | 23.67% |
| Total Depreciation and Amortization | 26.03% | -5.07% | -14.06% | 8.55% | -14.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.40% | 183.20% | 97.96% | 13.60% | -19.57% |
| Change in Net Operating Assets | -20.72% | 525.99% | -491.93% | -91.99% | -29.26% |
| Cash from Operations | -91.16% | 41.51% | -4.57% | -88.60% | 23.84% |
| Capital Expenditure | -- | 26.09% | -27.78% | 98.12% | -248.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,862.09% | 67.62% | 33.12% | -121.41% | -- |
| Cash from Investing | -4,519.97% | 67.15% | 32.77% | -36.60% | -802.55% |
| Total Debt Issued | 114.08% | -200.17% | -- | -100.00% | -78.51% |
| Total Debt Repaid | -118.50% | -1.20% | 25.74% | 95.08% | -1,467.13% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 85.02% | -235.69% | 541.87% | 95.01% | -1,067.58% |
| Foreign Exchange rate Adjustments | -26,400.00% | 96.93% | -180.69% | -34.42% | -29.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -659.67% | 21.22% | 20.47% | 10.87% | -217.25% |